Search
Mar 19
BMO's Evan Seigerman takes a deep dive into the obesity space ahead of an investor summit
Evan Seigerman breaks down which companies and technologies are at the forefront of the the GLP space.
Nov 16, 2023
BMO's Evan Seigerman joins Analyst Thursdays from London
Evan Seigerman discusses news from #AHA23, what's going on with Structure, Verve's polarizing result, Neurocrine, Vertex, Pfizer and more.
Aug 31, 2023
BMO Capital Markets’ Evan Seigerman joins BiotechTV for Analyst Thursdays
Evan Seigerman gives his take on biotech and the CMS list, Lilly, Amgen, Skyscraper-01, Structure Therapeutics, Disc Medicine and Replimune.
.png){kind=logo}
